Testing effectiveness (Phase 2)Ended earlyNCT04987294
What this trial is testing
Phase IIa Study of ALLN-346 (Engineered Urate Oxidase) in Subjects With Hyperuricemia, Gout and Chronic Kidney Disease
Who this might be right for
HyperuricemiaGoutChronic Kidney Diseases
Allena Pharmaceuticals 19